← Back to all trials
Recruiting
NCT05658081
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Conditions: Crohn Disease, Recurrence
Sex: All
Ages: 16 Years – 60 Years
Phase: NA
Enrollment: 236
Sponsor: Jinling Hospital, China
Location: China
Summary
The postoperative recurrence of Crohn's diseases (CD) remains high.
Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients.
Its impact on the postoperative recurrence of CD was unknown.
Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored.
The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.
Eligibility Criteria
Inclusion Criteria:patients with Crohn's disease needing bowel resection and anastomosis;ileocolic anastomosis;written consent acquiredExclusion Criteria:patients underwent enterostomy;small bowel anastomosis;anticipating other trial.
Source: ClinicalTrials.gov (NCT05658081). StuddyBuddy aggregates publicly available trial information.